Bilal A Al-Jaidi (Bilal Al-Jaidi)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Molecular Docking

Structure Activity Relationship

Major Depressive Disorder

Acinetobacter Baumannii

Top Venues

Antibiotics (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

Current issues in molecular biology

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Omar Salem Gammoh, Bilal Sayaheen, Mervat M Alsous, Ahmed Mohammad Al-Smadi, Bilal A Al-Jaidi, Alaa A A Aljabali
The Prevalence and Correlates of Depression, Anxiety, and Insomnia among Camp Residing Palestinian Women Migrants during the Outbreak of the War on Gaza: A Cross-Sectional Study from Jordan. Medicina (Kaunas, Lithuania) 60 (8) (2024)
Omar Salem Gammoh, Esam Y Qnais, Rabaa Y Athamneh, Bilal A Al-Jaidi, Deniz Al-Tawalbeh, Sara Altaber, Abdelrahim Alqudah, Alaa A A Aljabali, Murtaza M Tambuwala
Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram. Current issues in molecular biology 45 (9) (2023)
Bilal A Al-Jaidi, Pran Kishore Deb, Soha Taher Telfah, Abdel Naser Dakkah, Yazan A Bataineh, Qutaiba Ahmed Al Khames Aga, Mohammad A Al-Dhoun, Ala' Ali Ahmad Al-Subeihi, Haifa'a Marouf Odetallah, Sanaa K Bardaweel, Raghu Prasad Mailavaram, Katharigatta Narayanaswamy Venugopala, Anroop Balachandran Nair
Synthesis and evaluation of 2,4,5-trisubstitutedthiazoles as carbonic anhydrase-III inhibitors. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Katharigatta Narayanaswamy Venugopala, Vijayakumar Uppar, Sandeep Chandrashekharappa, Abdallah H Hassan, Melendhran Pillay, Pran Kishore Deb, Mohamed A Morsy, Bandar E Al-Dhubiab, Mahesh V Attimarad, Anroop Balachandran Nair, Sreeharsha Nagaraja, Christophe Tratrat, Abdulmuttaleb Yousef Jaber, Rashmi Venugopala, Raghu Prasad Mailavaram, Bilal A Al-Jaidi, Mahmoud Kandeel, Michelyne Haroun, Basavaraj Padmashali
Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-a]quinoline Derivatives: Molecular Target Identification and Molecular Docking Studies. Antibiotics (Basel, Switzerland) 9 (5) (2020)